Assessment of Cerebral Vasoreactivity Using Near-infrared Spectroscopy (NIRS) in Infants (VARO)
NCT ID: NCT02429154
Last Updated: 2018-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2015-09-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Abdominal Tissue Oxygenation in Premature Infants Using Near Infrared Spectroscopy
NCT01855347
NIRS to Monitor Abdominal Tissue Oxygen Saturation in Preterm Infants
NCT03706976
Near-infrared Spectroscopy in Cerebral Oxygenation Monitoring in Full Term Neonates
NCT05158881
Application of Lung Near-Infrared Spectroscopy (NIRS) in Preterm Infants
NCT05961670
Influence of IPV on GOR in Infants From 0 to 12 Months.
NCT02124863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We, therefore designed this prospective observational comparative effectiveness study in order to characterize the potential beneficial effect of permissive hypercapnia on cerebral perfusion in infants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normocapnia
The Child will be ventilated in order to achieve an end-tidal carbon dioxide (ETCO2) of 5.5 kiloPascal (kPa). Measurements will be performed after steady state condition. Then the ventilation will be reduced to allow ETCO2 to reach 6.5 kPa before repeating the measurements. Finally, the child will be again ventilated to obtain a normocapnia condition.
Normocapnia
Normoventilation in order to have an end-tidal carbon dioxide (ETCO2) of 5.5 kiloPascal (kPa)
Mild Hypercapnia
The Child will be ventilated in order to achieve a ETCO2 of 6.5 kPa. Measurements will be performed after steady state condition. Then the ventilation will be increased to allow ETCO2 to reach 5.5 kPa before repeating the measurements. Finally, the child will be again ventilated to obtain a mild hypercapnic condition
Mild Hypercapnia
Decrease in minute ventilation in order to increase ETCO2 to 6.5 kPa
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normocapnia
Normoventilation in order to have an end-tidal carbon dioxide (ETCO2) of 5.5 kiloPascal (kPa)
Mild Hypercapnia
Decrease in minute ventilation in order to increase ETCO2 to 6.5 kPa
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* for elective surgery requiring general anesthesia and endotracheal intubation
Exclusion Criteria
* all infants where no access to the forehead is possible as a consequence of the operating field
1 Day
1 Year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Walid HABRE
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Walid HABRE
Associated Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walid Habre, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geneva Children's Hospital
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schopfer L, Habre W, Pichon I, Fodor GH. Effect of Permissive Mild Hypercapnia on Cerebral Vasoreactivity in Infants: A Randomized Controlled Crossover Trial. Anesth Analg. 2021 Oct 1;133(4):976-983. doi: 10.1213/ANE.0000000000005325.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-204
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.